ExoticRx · exoticrx.com/drugs/bedinvetmab
US brand names:Librela
Bedinvetmab is dosed at 0.5–1 mg/kg SC q28 days in dogs, per Plumb's Veterinary Drug Handbook, 9th Ed. Verify against current literature before clinical use.
Caninized anti-NGF monoclonal antibody. Binds and neutralizes nerve growth factor, reducing OA pain signaling.
FDA-approved for OA pain in dogs. Monthly SC injection. Weight-based dosing. Injection site reactions rare. UTI reports in clinical trials. Not for breeding dogs.
Species references:All Dog (Domestic) drugs
Each ExoticRx dose rule is graded by the strength of its primary evidence — see the editorial process.
A dog/cat sample is shown here. Cited dosing for all 1 species — reptiles, birds, pocket pets, livestock, and equine — is free on the per-species pages above. Pro adds the weight-based calculator for every species.
| Species | Route | Dose | Frequency | Evidence | Source |
|---|---|---|---|---|---|
| Dog (Domestic) | SC | 0.5–1 mg/kg | q28 days | Strong | Plumb's Veterinary Drug Handbook, 9th Ed |
Upgrade to Pro or Student to unlock the full dose ranges and frequency for every species. The drug's mechanism, warnings, indications, and cited sources are free to read.
View PlansSource citations and evidence levels available on the live page. Reference only — verify against current literature before clinical use.